Australia In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

Published : Apr-2020

No. of Pages : 503

order by fax Inquire before Buying request discount

Table of Contents
2 Introduction 10
3 In Vitro Diagnostics Market, Australia 44
4 Cardiac Disease Market, Australia 59
5 Clinical Chemistry Market, Australia 74
6 Hematological Disorders Market, Australia 89
7 Hormonal Disorders Market, Australia 114
8 Infectious Disease Market, Australia 129
9 IVD Analyzers and Reagents Market, Australia 198
10 Metabolic Disorder Market, Australia 236
11 Oncology Market, Australia 250
12 Women's Health Market, Australia 292
13 Overview of Key Companies in Australia, In Vitro Diagnostics Market 317
14 In Vitro Diagnostics Market Pipeline Products 321
15 Financial Deals Landscape 325
16 Recent Developments 376
17 Appendix 497

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2015-2025 48
Table 2: In Vitro Diagnostics Market, Australia, Category Contribution by Revenue ($m), 2018 51
Table 3: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2015-2020 53
Table 4: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2021-2025 54
Table 5: In Vitro Diagnostics Market, Australia, Volume (Units), 2015-2025 56
Table 6: In Vitro Diagnostics Market, Australia, Volume (Units), Historic, 2015-2020 58
Table 7: In Vitro Diagnostics Market, Australia, Volume (Units), Forecast, 2021-2025 59
Table 8: In Vitro Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 61
Table 9: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2015-2020 63
Table 10: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2021-2025 63
Table 11: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 65
Table 12: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 66
Table 13: Cardiac Disease Market, Australia, Volume (Units), 2015-2020 68
Table 14: Cardiac Disease Market, Australia, Volume (Units), 2021-2025 68
Table 15: Cardiac Marker Tests Market, Australia, Volume (Units), 2015-2020 70
Table 16: Cardiac Marker Tests Market, Australia, Volume (Units), 2021-2025 71
Table 17: Cardiac Disease Market, Australia, Average Price ($), 2015-2020 72
Table 18: Cardiac Disease Market, Australia, Average Price ($), 2021-2025 73
Table 19: Cardiac Disease Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 74
Table 20: Cardiac Disease Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 76
Table 21: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, 2015-2020 78
Table 22: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, 2021-2025 78
Table 23: Substrates Market, Australia, Revenue ($m), USD Constant, 2015-2020 80
Table 24: Substrates Market, Australia, Revenue ($m), USD Constant, 2021-2025 81
Table 25: Clinical Chemistry Market, Australia, Volume (Units), 2015-2020 83
Table 26: Clinical Chemistry Market, Australia, Volume (Units), 2021-2025 83
Table 27: Substrates Market, Australia, Volume (Units), 2015-2020 85
Table 28: Substrates Market, Australia, Volume (Units), 2021-2025 86
Table 29: Clinical Chemistry Market, Australia, Average Price ($), 2015-2020 87
Table 30: Clinical Chemistry Market, Australia, Average Price ($), 2021-2025 88
Table 31: Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 89
Table 32: Clinical Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 90
Table 33: Hematological Disorders Market, Australia, Segment Contribution (%), 2018 92
Table 34: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2020 94
Table 35: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2021-2025 94
Table 36: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 96
Table 37: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 97
Table 38: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 99
Table 39: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 100
Table 40: Hematological Disorders Market, Australia, Volume (Units), 2015-2020 102
Table 41: Hematological Disorders Market, Australia, Volume (Units), 2021-2025 102
Table 42: Hematology Tests Market, Australia, Volume (Units), 2015-2020 104
Table 43: Hematology Tests Market, Australia, Volume (Units), 2021-2025 105
Table 44: Hemostasis Tests Market, Australia, Volume (Units), 2015-2020 107
Table 45: Hemostasis Tests Market, Australia, Volume (Units), 2021-2025 108
Table 46: Hematological Disorders Market, Australia, Average Price ($), 2015-2020 109
Table 47: Hematological Disorders Market, Australia, Average Price ($), 2021-2025 111
Table 48: Hematological Disorders Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 113
Table 49: Hematological Disorders Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 115
Table 50: Hormonal Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2020 117

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2015-2025 47
Figure 2: In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2018 49
Figure 3: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2018 50
Figure 4: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2015-2025 52
Figure 5: In Vitro Diagnostics Market, Australia, Volume (Units), 2015-2025 55
Figure 6: In Vitro Diagnostics Market, Australia, Volume (Units), Historic, 2015-2025 57
Figure 7: In Vitro Diagnostics Market, Australia, Company Share (%) 2018 60
Figure 8: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2015-2025 62
Figure 9: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 64
Figure 10: Cardiac Disease Market, Australia, Volume (Units), 2015-2025 67
Figure 11: Cardiac Marker Tests Market, Australia, Volume (Units), 2015-2025 69
Figure 12: Cardiac Disease Market, Australia, Company Share (%) 2018 75
Figure 13: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, 2015-2025 77
Figure 14: Substrates Market, Australia, Revenue ($m), USD Constant, 2015-2025 79
Figure 15: Clinical Chemistry Market, Australia, Volume (Units), 2015-2025 82
Figure 16: Substrates Market, Australia, Volume (Units), 2015-2025 84
Figure 17: Clinical Chemistry Market, Australia, Company Share (%) 2018 90
Figure 18: Hematological Disorders Market, Australia, Revenue Mix ($m), 2018 91
Figure 19: Hematological Disorders Market, Australia, Segment Contribution (%), 2018 92
Figure 20: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2025 93
Figure 21: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 95
Figure 22: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 98
Figure 23: Hematological Disorders Market, Australia, Volume (Units), 2015-2025 101
Figure 24: Hematology Tests Market, Australia, Volume (Units), 2015-2025 103
Figure 25: Hemostasis Tests Market, Australia, Volume (Units), 2015-2025 106
Figure 26: Hematological Disorders Market, Australia, Company Share (%) 2018 114
Figure 27: Hormonal Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2025 116
Figure 28: Thyroid Function Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 118
Figure 29: Hormonal Disorders Market, Australia, Volume (Units), 2015-2025 121
Figure 30: Thyroid Function Tests Market, Australia, Volume (Units), 2015-2025 123
Figure 31: Hormonal Disorders Market, Australia, Company Share (%) 2018 129
Figure 32: Infectious Disease Market, Australia, Revenue Mix ($m), 2018 131
Figure 33: Infectious Disease Market, Australia, Segment Contribution (%), 2018 132
Figure 34: Infectious Disease Market, Australia, Revenue ($m), USD Constant, 2015-2025 134
Figure 35: Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 139
Figure 36: Clostridium difficile Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 141
Figure 37: Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 143
Figure 38: Hepatitis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 145
Figure 39: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 147
Figure 40: Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 150
Figure 41: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 152
Figure 42: Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 154
Figure 43: Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 156
Figure 44: Treponema pallidum Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 158
Figure 45: Infectious Disease Market, Australia, Volume (Units), 2015-2025 161
Figure 46: Chlamydia Trachomatis Tests Market, Australia, Volume (Units), 2015-2025 166
Figure 47: Clostridium difficile Tests Market, Australia, Volume (Units), 2015-2025 168
Figure 48: Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), 2015-2025 171
Figure 49: Hepatitis Tests Market, Australia, Volume (Units), 2015-2025 173

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Australia In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027